There are 2867 resources available
76P - Second interim analysis of INFINITY: A registry on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice
Presenter: Uwe Martens
Session: Poster session 01
77P - Hypermethylation of genes HIST1H4F, Septin9 and RASSF1 as the potential biomarker for nasopharyngeal carcinoma screening
Presenter: Dingsheng Wen
Session: Poster session 01
78P - Association between obesity, sex, and overall survival in patients with metastatic cancers treated with first- or second-line immune checkpoint inhibitors
Presenter: Mingjia Li
Session: Poster session 01
79P - Molecular characterization of KRAS NSCLC all stages: A single-center cohort
Presenter: Carla Climent Vicente
Session: Poster session 01
80P - The analysis of ROS1 fusions characteristics in Chinese solid tumor patients
Presenter: Yujing Lin
Session: Poster session 01
81P - NF1 mutation as an indicator stratified patients benefit from immune checkpoint inhibitors in gastroesophageal cancers
Presenter: Haiping Xiao
Session: Poster session 01
82P - Exploring the prognostic role of DNA damage sensing deficiency for immune checkpoint blockade in diverse cancer types
Presenter: Yang Shao
Session: Poster session 01
83P - Patterns of trophoblast cell surface antigen 2 (TROP2) and epithelial cell adhesion molecule (EPCAM) expression in human tumors: A tissue microarray study on 14,766 tumors
Presenter: David Dum
Session: Poster session 01
84P - Pharmacodynamic marker modulation of the selective WEE1 inhibitor Debio 0123 in patient biopsies from phase I clinical trial
Presenter: Hans Gelderblom
Session: Poster session 01
85P - A circulating, surrogate-systemic biomarker correlates with anti-tumor benefit on LNS8801 therapy
Presenter: Justine Cohen
Session: Poster session 01